UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
International journal of cancer, ISSN 0020-7136, 01/2016, Volume 138, Issue 1, pp. 171 - 181
prognostic | SCCHN | postoperative chemoradiotherapy | CD8 | DKTK‐ROG | HPV | DKTK-ROG | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Tumor Virus Infections - virology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Papillomaviridae - genetics | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Neoplasm Grading | Postoperative Care | Biomarkers, Tumor - metabolism | CD8-Positive T-Lymphocytes - metabolism | Adult | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Papillomavirus Infections - virology | Papillomavirus Infections - complications | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Immunophenotyping | Treatment Outcome | Head and Neck Neoplasms - pathology | Tumor Virus Infections - complications | Carcinoma, Squamous Cell - etiology | Phenotype | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Head and Neck Neoplasms - etiology | Aged | Biomarkers, Tumor - genetics | Head and Neck Neoplasms - mortality | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | DNA, Viral | Lymphocytes, Tumor-Infiltrating - immunology | Consortia | Cancer patients | Care and treatment | Squamous cell carcinoma | Lymphocytes | Patient outcomes | Oncology, Experimental | Radiation | Research | Papillomavirus infections | Cancer | Surgery | Medical prognosis | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
International journal of cancer, ISSN 0020-7136, 05/2018, Volume 142, Issue 9, pp. 1911 - 1925
SCCHN | prognostic biomarker | Hsp70 | NK cells | IHC | retrospective trial | Life Sciences & Biomedicine | Oncology | Science & Technology | Immunohistochemistry | Squamous Cell Carcinoma of Head and Neck - metabolism | Head and Neck Neoplasms - virology | Prognosis | Humans | Middle Aged | DNA, Viral - metabolism | Head and Neck Neoplasms - therapy | Tumor Suppressor Protein p53 - metabolism | Male | Squamous Cell Carcinoma of Head and Neck - immunology | Head and Neck Neoplasms - metabolism | Squamous Cell Carcinoma of Head and Neck - virology | HSP70 Heat-Shock Proteins - metabolism | Head and Neck Neoplasms - immunology | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Killer Cells, Natural - immunology | Female | Retrospective Studies | Squamous Cell Carcinoma of Head and Neck - therapy | Neoplasm Staging | Human papillomavirus 16 - genetics | Lymphocytes, Tumor-Infiltrating - immunology | Squamous cell carcinoma | Care and treatment | Relapse | Killer cells | Oncology, Experimental | Radiation | Heat shock proteins | Research | Tumor proteins | Cancer | Diseases | Lymphocyte receptors | Tumor cells | p53 Protein | Hsp70 protein | Paraffin | Tissues | Survival | Patients | Cell surface | Cisplatin | Metastases | Consortia | Surgery | Medical prognosis | Neck | CD56 antigen | Indicators | Deoxyribonucleic acid--DNA | Tumors | Heat shock | Index Medicus | Tumor Markers and Signatures
Journal Article
Scientific reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 13206 - 11
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 06/2012, Volume 30, Issue 16, pp. 1926 - 1933
Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Medical sciences | Tumors | Follow-Up Studies | Rectal Neoplasms - surgery | Humans | Middle Aged | Postoperative Period | Male | Treatment Outcome | Combined Modality Therapy | Rectal Neoplasms - therapy | Chemoradiotherapy | Rectal Neoplasms - mortality | Antimetabolites, Antineoplastic - administration & dosage | Disease-Free Survival | Fluorouracil - administration & dosage | Adult | Female | Neoadjuvant Therapy | Aged | Rectal Neoplasms - pathology | Chemotherapy, Adjuvant | Germany | Index Medicus
Journal Article
International journal of cancer, ISSN 0020-7136, 08/2017, Volume 141, Issue 3, pp. 594 - 603
prognostic | SCCHN | chemoradiotherapy | PD‐1/PD‐L1 | CD8 | HPV | PD-1/PD-L1 | Life Sciences & Biomedicine | Oncology | Science & Technology | Papillomavirus Infections - complications | Head and Neck Neoplasms - virology | Prognosis | Follow-Up Studies | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Programmed Cell Death 1 Receptor - metabolism | Male | Survival Rate | Chemoradiotherapy, Adjuvant | Head and Neck Neoplasms - metabolism | Head and Neck Neoplasms - pathology | B7-H1 Antigen - metabolism | Neoplasm Grading | Biomarkers, Tumor - metabolism | Female | Neoplasm Staging | Papillomaviridae - physiology | Cancer patients | Care and treatment | Squamous cell carcinoma | Analysis | Oncology, Experimental | Radiation | Metastasis | Research | Papillomavirus infections | Cancer | PD-1 protein | CD8 antigen | Viruses | Genomes | Metastases | Consortia | Human papillomavirus | Lymphocytes | Surgery | Neck | Deoxyribonucleic acid--DNA | Head | Markers | Radiation therapy | Gene expression | Patients | Survival | Inhibitors | Immune checkpoint | PD-L1 protein | Head and neck cancer | Infiltration | Tumors | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 979 - 989
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Chemoradiotherapy, Adjuvant - adverse effects | Male | Chemoradiotherapy, Adjuvant - mortality | Neoadjuvant Therapy - mortality | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Time Factors | Dose Fractionation | Female | Rectal Neoplasms - pathology | Chemotherapy, Adjuvant | Drug Administration Schedule | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Treatment Outcome | Rectal Neoplasms - therapy | Adenocarcinoma - secondary | Disease Progression | Rectal Neoplasms - mortality | Disease-Free Survival | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Intention to Treat Analysis | Aged | Infusions, Intravenous | Neoplasm Staging | Germany | Adenocarcinoma - mortality | Clinical trials | Research | Oncology, Experimental | Colorectal cancer | Cancer | Medical informatics | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 9, pp. 835 - 844
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Treatment Outcome | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Radiotherapy | Rectal Neoplasms - therapy | Rectal Neoplasms - mortality | Disease-Free Survival | Digestive System Surgical Procedures | Neoadjuvant Therapy | Rectal Neoplasms - pathology | Retrospective Studies | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Medical colleges | Care and treatment | Surgical clinics | Patient outcomes | Oncology, Experimental | Radiation | Research | Tumors | Cancer | Medicine, Experimental | Medical research | Analysis | Colorectal cancer | Index Medicus
Journal Article
Radiation oncology (London, England), ISSN 1748-717X, 12/2011, Volume 6, Issue 1, pp. 177 - 177
Antibodies | Tki | Radiotherapy | Toxicity | Molecular targeted drugs | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Chemoradiotherapy - adverse effects | Molecular Targeted Therapy - adverse effects | Neoplasms - therapy | Antineoplastic Agents - adverse effects | Humans | Drugs | Complications and side effects | Comparative analysis | Chemotherapy | Weight control | Clinical trials | Radiation therapy | Clinical medicine | Cancer therapies | Drug dosages | Manuscripts | Index Medicus | toxicity | radiotherapy | antibodies | TKI | molecular targeted drugs
Journal Article